How the “Father of Modern Time” Helped Build the Internet

Bringing together leaders, lawmakers and lawbreakers. Host Luke Fox explores how innovations in business and technology are redefining our trust in security measures.

 

There are many components of trust throughout the internet, and most people don’t realize how far those layers of trust go back. The Trust Revolution looked backward to the internet’s early days and the development of the Network Time Protocol (NTP), invented by guest Dr. David Mills. Dr. Mills, a computer engineer and Internet pioneer is known as the Father of Modern Time.

“Protocols and algorithms to synchronize time were my sandbox.” Dr. Mills was on the first task force of the internet in the 1970s. “I was fascinated by what accurate time could be used for,” he said.

One of the first experiments was synchronizing a clock with different power grids. When a grid began to lose up to five seconds, it was “time to put more coal on the burner.”

“Now that the internet was going to be a working item, there were issues with protocols,” he said. The question was should they use TCP/IP and if that should become the standard. It did, and without it, the internet might still be just a concept. – Dr. David Mills

Time synchronization became more accurate but wasn’t exact enough, so he developed an algorithm to compensate for disturbances, getting the time down to the low tenth of milliseconds.

Today, technology users take time for granted, thinking it’s fixed, and never questioning the time it provides. All users can give thanks to Dr. Mills for the innovation behind NTP.

He and his early internet colleagues also did something rather remarkable in the 1970s—video calls and streaming. They were “zooming” way before the rest of the world. “We created these distributed conferences and broadcast them to willing universities,” Dr. Mills explained. In those days, bandwidth was low, and infrastructure was just being built.

Dr. Mills was also the first director of the Internet Architecture Task Force. “Now that the internet was going to be a working item, there were issues with protocols,” he said. The question was should they use TCP/IP and if that should become the standard. It did, and without it, the internet might still be just a concept.

Catch Up On Previous Episodes of The Trust Revolution!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More